BLUEJET Share Price Performance
₹0
-970.70 (-100.00%)
Price ₹0
Fair Value₹501.00
Share Pricen/a
Narrative Update • Jul 09
Blue Jet Healthcare Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 15 Fair Values set on narratives written by author
BLUEJET Community Narratives
AN
Fair Value
·Fair Value ₹501 16.7% overvalued intrinsic discount
Analysts Lower Blue Jet Healthcare Valuation as Revenue Growth Projections Moderate Amid Company Updates
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
Fair Value
·Fair Value ₹600 2.6% undervalued intrinsic discount
Aging Populations And Chronic Disease Will Feed Indian Pharma Outsourcing
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
Fair Value
·Fair Value ₹370 58.0% overvalued intrinsic discount
Escalating Regulatory And Supply Risks Will Weaken Outlook
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Escalating Regulatory And Supply Risks Will Weaken Outlook
Blue Jet Healthcare makes key ingredients used in medicines, but tougher rules, environmental costs, and reliance on overseas suppliers could squeeze profits and disrupt production. It also depends heavily on a small set of customers, raising the stakes if relationships shift while rivals move faster on automation.Read more
AN
₹370
58.0% overvalued intrinsic discount
Fair Value
Revenue
17.49% p.a.
Profit Margin
24.63%
Future PE
24.09x
Price in 2029
₹524.72
Analysts Lower Blue Jet Healthcare Valuation as Revenue Growth Projections Moderate Amid Company Updates
Blue Jet Healthcare looks set to ride a global push by drugmakers to diversify suppliers, while moving into more specialized products that could lift profits over time. But recent pressure on its main business line and the cost and complexity of big expansion plans raise questions about how steady growth will be.Read more
AN
₹501
16.7% overvalued intrinsic discount
Fair Value
Revenue
17.3% p.a.
Profit Margin
25.34%
Future PE
31.87x
Price in 2029
₹710.5
Aging Populations And Chronic Disease Will Feed Indian Pharma Outsourcing
Blue Jet Healthcare is betting big on new factories, more in-house production, and faster research to win larger outsourced drug-ingredient contracts as global buyers shift more work to India. That growth story comes with a catch: the business leans heavily on a few major customers and faces tougher competition and regulatory hurdles that could derail the upside.Read more
AN
₹600
2.6% undervalued intrinsic discount
Fair Value
Revenue
19.27% p.a.
Profit Margin
25.83%
Future PE
35.6x
Price in 2029
₹850.9
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
BLUEJET: Rich Multiple Will Be Pressured By Aggressive Revenue And Margin Assumptions
Fair Value: ₹370 58.0% overvalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
BLUEJET: Board Decisions On Dividends And Fundraising Will Shape Future Returns
Fair Value: ₹501 16.7% overvalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
BLUEJET: Higher Margins And Capital Plans Will Support Future Upside
Fair Value: ₹600 2.6% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Blue Jet Healthcare Limited Key Details
About BLUEJET
- Founded
- 1968
- Employees
- 196
- CEO
- WebsiteView website
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.
